{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:53:15Z","timestamp":1778604795680,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T00:00:00Z","timestamp":1392595200000},"content-version":"vor","delay-in-days":1388,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NicOx SA"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.joca.2009.12.013","type":"journal-article","created":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T04:39:50Z","timestamp":1266381590000},"page":"629-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study"],"prefix":"10.1016","volume":"18","author":[{"given":"T.J.","family":"Schnitzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kivitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Frayssinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Duquesroix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2009.12.013_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/ard.60.2.91","article-title":"Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care","volume":"60","author":"Peat","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2009.12.013_bib2","series-title":"Osteoarthritis","first-page":"9","article-title":"Epidemiology of osteoarthritis","author":"Felson","year":"2003"},{"key":"10.1016\/j.joca.2009.12.013_bib3","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/rheumatology\/kei049","article-title":"The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition","volume":"44","author":"Gupta","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.joca.2009.12.013_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00002281-200403000-00007","article-title":"Musculoskeletal aging","volume":"16","author":"Leveille","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.joca.2009.12.013_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2458-6-258","article-title":"Disabling knee pain \u2013 another consequence of obesity: results from a prospective cohort study","volume":"6","author":"Jinks","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.joca.2009.12.013_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"FitzGerald","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joca.2009.12.013_bib7","first-page":"91","article-title":"Actions and interactions of endothelins, prostacyclin and nitric oxide in the gastric mucosa","volume":"44","author":"Lopez-Belmonte","year":"1993","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.joca.2009.12.013_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2474-8-73","article-title":"Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk","volume":"8","author":"Moore","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"issue":"Suppl 5","key":"10.1016\/j.joca.2009.12.013_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2165\/00003495-199200445-00007","article-title":"Cardiovascular risks and benefits of perioperative nonsteroidal anti-inflammatory drug treatment","volume":"44","author":"Camu","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.joca.2009.12.013_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1993.00410040045007","article-title":"A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure","volume":"153","author":"Pope","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.joca.2009.12.013_bib11","doi-asserted-by":"crossref","first-page":"M91","DOI":"10.1093\/geronj\/48.3.M91","article-title":"Nonsteroidal anti-inflammatory drugs and blood pressure in an elderly population","volume":"48","author":"Chrischilles","year":"1993","journal-title":"J Gerontol"},{"key":"10.1016\/j.joca.2009.12.013_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","article-title":"Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis","volume":"121","author":"Johnson","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joca.2009.12.013_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00002512-199812010-00003","article-title":"NSAIDs and blood pressure. Clinical importance for older patients","volume":"12","author":"Johnson","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1016\/j.joca.2009.12.013_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0149-2918(03)90003-8","article-title":"The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents","volume":"25","author":"Armstrong","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.joca.2009.12.013_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/01.HYP.0000149684.01903.b8","article-title":"Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?","volume":"45","author":"Grover","year":"2005","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.joca.2009.12.013_bib16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.dld.2007.09.001","article-title":"NSAIDs, coxibs, CINOD and H2S-releasing NSAIDS: what lies beyond the horizon","volume":"39","author":"Fiorucci","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.joca.2009.12.013_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/1-4020-5688-5_1","article-title":"Anti-inflammatory drugs in the 21st century","volume":"42","author":"Rainsford","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.joca.2009.12.013_bib18","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1038\/sj.bjp.0706458","article-title":"The discovery of nitric oxide and its role in vascular biology","volume":"147","author":"Moncada","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"12 Suppl 4","key":"10.1016\/j.joca.2009.12.013_bib19","first-page":"2","article-title":"Aspects of nitric oxide in health and disease: a focus on hypertension and cardiovascular disease","volume":"8","author":"Giles","year":"2006","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.joca.2009.12.013_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/1043-6618(95)80049-2","article-title":"Anti-inflammatory potency and gastrointestinal toxicity of a new compound, NO-naproxen","volume":"31","author":"Cuzzolin","year":"1995","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.joca.2009.12.013_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2036.1997.115286000.x","article-title":"NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects","volume":"11","author":"Davies","year":"1997","journal-title":"Aliment Pharm Ther"},{"issue":"6","key":"10.1016\/j.joca.2009.12.013_bib22","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/art.21586","article-title":"Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of osteoarthritis of the knee","volume":"53","author":"Schnitzer","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.joca.2009.12.013_bib23","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3899\/jrheum.081011","article-title":"Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee","volume":"36","author":"Karlsson","year":"2009","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.joca.2009.12.013_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/00365520510024197","article-title":"Dose-effect comparisons of the CINOD AZD3582 and naproxen on upper gastrointestinal tract mucosal injury in healthy subjects","volume":"41","author":"Wilder-Smith","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.joca.2009.12.013_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.HYP.0000150859.47929.8e","volume":"45","author":"Pickering","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.joca.2009.12.013_bib26","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.joca.2009.12.013_bib27","first-page":"1932","article-title":"Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis","volume":"28","author":"Ehrich","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2009.12.013_bib28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/ard.2004.023572","article-title":"A randomized, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis","volume":"64","author":"Lohmander","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2009.12.013_bib29","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/gut.52.11.1537","article-title":"Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans","volume":"52","author":"Hawkey","year":"2003","journal-title":"Gut"},{"issue":"119","key":"10.1016\/j.joca.2009.12.013_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.amjmed.2005.09.054","article-title":"Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study","volume":"3","author":"Singh","year":"2006","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.joca.2009.12.013_bib31","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1345\/aph.1H341","article-title":"Nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk: are they safe?","volume":"41","author":"Waksman","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.joca.2009.12.013_bib32","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.joca.2009.12.013_bib33","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1185\/030079907X219553","article-title":"Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension","volume":"23","author":"Morrison","year":"2007","journal-title":"Curr Med Res Opin"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458410000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458410000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:22:13Z","timestamp":1761016933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458410000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1063458410000555"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2009.12.013","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2009.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}